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THE vasculature of tumours has been extensively studied by a variety of
techniques, but interest has largely centred upon pure morphology. It is only
recently that evidence has emerged for the existence of a special haemodynamic
state peculiar to neoplastic growth and possibly of fundamental biological signifi-
cance.
The work ofYoung, Lumsden and Stalker (1950), and Shivas (1959) showing the
existence of a capillary and venous hypertension in Brown-Pearce carcinoma has
prompted this study of its vascularisation-in liver, to determine whether it
conforms to the fairly clearly defined pattern of preferential supply from the
hepatic artery. The concept of neoplastic haemodynamics confers a new impor-
tance upon the positive results obtained, and the findings ofearlier workers must be
re-examined.
The present study utilised an injection technique with neoprene latex, which
possesses good power of penetration of the microcirculation (Lieb, 1940) and
produces a three-dimensional cast easily studied under the dissecting microscope.
MATERIAL AND METHODS
Healthy rabbits of mixed strains, aged 6-8 months, and weighing 2-3 kilo-
grammes, were used. Under nembutal anaesthesia, supplemented with ether as
necessary, laparotomy was performed through a short upper midline incision and
fresh fragments of Brown-Pearce carcinoma from a donor animal were implanted
into the liver parenchyma using standard lumbar puncture needles. The operation
was performed on 20 animals which were killed at intervals varying from 10 to
21 days after inoculation. Where a visible or palpable tumour was present the
liver was removed after identification of the portal vein and hepatic artery, and
perfused with normal saline through portex cannulae at pressures approximating to
the normal in the living animal (130 mm. Hg in the hepatic artery, 15 cm. water
in the portal vein). When the effluent from the hepatic vein ran consistently
clear, coloured neoprene latex was injected under similar pressures. The cast was
then fixed in a bath ofconcentrated hydrochloric acid for 48 hours, with a change of
acid at 24 hours. Fat was then cleared by washing in 2-ethoxy-ethanol for 24
hours, and the casts were stored in distilled water with a crystal of thymol to
prevent the growth offungus. Theimportance ofusingfreshneoprenelatex cannot
be too strongly stressed, as prolonged storage undoubtedly diminishes the powers of
penetration of the latex.
RESULTS
Tumour growth was obtained in 8 ofthe 20 animals. Four livers were perfused
through the portal vein, 1 through the hepatic artery and 3 through both vessels
simultaneously using different colours of neoprene. The findings are summarised
in Table I.VASCULARISATION OF BROWN-PEARCE CARCINOMA
TABLE I.-ExperimentalFindings
Animal
Number Route of injection Findings
2 Portal vein Filling defect in cast: no filling of tumour vessels.
3 Portal vein . Filling defect in cast: no filling of tumour vessels.
4 . Portal vein . Filling defect in cast: no filling of tumour vessels.
6 . Portal vein/Hepatic artery . Foci of tumour vessels filled from hepatic artery: no
evidence of filling from portal vein.
9 Portal vein/Hepatic artery . Tumour vessels filled mainly from hepatic artery:
marginal filling from portal vein.
12 . Portal vein Filling defect in cast: no filling of tumour vessels.
16 . Hepatic artery Complete filling of tumour vessels from hepatic artery:
no filling from portal vein.
17 . Portal vein/Hepatic artery Tumour vessels filled mainly from hepatic artery:
marginal filling from portal vein.
It seems clear that the blood supply to Brown-Pearce carcinoma implanted in
the rabbit liver is essentially derived from the hepatic artery when the circulation
is studied 10-21 days after implantation. Perfusion through the portal vein
produces a cast which shows the site of tumour growth as a " filling defect "
(Fig. 1). There is, however, some evidence (Case 9) of a marginal connection with
the portal circulation following simultaneous perfusion through hepatic artery
and portal vein (Fig. 3). The tumour vasculature displays a characteristic appear-
ance of twisted, strap-like vessels communicating freely to produce a rather
sponge-like appearance (Fig. 2). The channels are 5-8 times the diameter of the
hepatic sinusoids and smaller vessels were not observed in the tumour. Some
tortuosity and dilatation ofthe afferent hepatic artery branch was noted.
DISCUSSION
Thiersch (1865) displayed the blood supply oftumours by Indian ink injection,
as did Goldmann (1907) when he described the spiral coiling ofvessels and capillary
offshoots at the margins of growing tumours, and compared the vascularity of
carcinoma and sarcoma. Lewis (1927) made Indian ink injection studies of a
number of rat tumours and first pointed out that each type of tumour has a
characteristic vascular pattern. He wrote, " The blood vesselsdo not determine
the growth of the tumour; but the tumour determines the growth and pattern of
blood vessels ", and he speculated further on the physical properties of tumour
circulation, suggesting that necrosis was caused by the collapse of vessels under a
high " tissue pressure ". It is indeed remarkablethatthisideawasnotfollowedup.
The illogical concept of tumour " outgrowing its blood supply" remained the
popular explanation of focal necrosis in tumours, up to the present time.
In the last 25 years a considerable body of published work on the topic has
accumulated and is summarised in Table II. The salient points in our present
state ofknowledge may, however, be conveniently stated as follows:
1. Vessels within tumours appear abnormal in size, calibre and distribution,
radiologically, histologically, and in tissue culture, and the differentiation into
arterioles and venules seen in granulation tissue is rarely observed.
2. Large nutrient stem vessels outwith the tumour may show tortuosity and
dilatation.
3. Each individual type of tumour is characterised by a particular vascular
pattern.
4. The rate of growth of host vessels into implanted tumour seems faster than
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TABLE II.--Published Work on the Vascular Morphology of Tumours
Method of study
Dye injection and histology
Angiography
Micro-angiography
Histology
Transparent chamber techniques
Author
Waters and Green (1959)
Goldacre and Sylven (1962)
Hasegawa (1934)
Chin (1937)
Shinkawa (1939)
Braithwaite (1958)
Bohatyrschuk (1942)
Lagergren et al. (1958)
Lagergren et al. (1960)
Chang and Trembly (1961)
Rubin et al. (1964)
Rubin and Casarett (1966)
Coman and Sheldon (1946)
Von Haller (1952)
Scheid (1961)
Ide et al. (1939)
Algire (1943)
Algire and Chalkley (1945)
Youngner and Algire (1949)
Algire and Legallais (1951)
Williams (1951)
Merwin et al. (1953)
Sanders (1963)
Goodall et al. (1964)
Goodall et al. (1965)
Warren and Shubik (1966)
Warren (1967)
Witte and Goldenberg (1967)
into granulation tissue, resulting in the hypothesis ofa " vessel growth stimulating
substance " acting upon host vascular tissues.
5. Tumour necrosis is frequently observed. This may be a result of occlusion
ofvessels by extravascular pressure.
6. The response of tumour parenchyma to vascular occlusion is variable.
7. Hypotension in the host peripheral circulation may cause a reduction in the
vascularity ofa tumour associated with necrosis oftumour cells.
Quantitative studies have been rare until recently. Young, Lumsden and
Stalker (1950) demonstratedthatthe " tissuepressure " inBrown-Pearce carcinoma
is consistently much higher than in adjacent normal tissue, and Shivas (1955)
showed that this was also true in tumours grown intracerebrally, even in the pre-
sence ofraised intracranial pressure. The " tissue pressure " measured by Young
and his co-workers is the minimum pressure required to introduce a bland fluid
into the tissue through a hollow needle. It is thus in effect also the minimum
EXPLANATION OF PLATES
FIG. 1.-Cast of hepatic vasculature produced by injection via the portal vein. The site of
tumour growth is seen as a cavity or " filling defect ", as the injection mass fails to enter
it. x 3.
FIG. 2.-Cast of hepatic vasculature produced by injection via the hepatic artery. The
tumour vasculature is fully penetrated and appears as a sponge-like mesh of bizarre,
strap-like vessels (centre). x 14.
FIG. 3.-Simultaneous injection via hepatic artery and portal vein was only partially successful.
Tumour vessels can be seen within the cavity. Detailed study suggested some marginal
filling of tumour vessels from the portal circulation. x 7.
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hydrostatic pressure which must be exerted by a thin-walled blood vessel ifit is to
remain patent. These findings in Brown-Pearce carcinoma seem explicable only
on the basis of a special haemodynamic state embodying capillary and venous
hypertension.
The development of tumour vasculature in tissues such as liver which them-
selves possess a special circulation thus acquires a new importance. It has
interested many workers over the last 50 years. Segall (1923) gave the first
account, following injection of human livers with a barium gelatin preparation
in the post mortem room. He showed in a small number of cases that the vessels
in metastatic tumours filled when the hepatic artery was injected but not when
the injection was made through the portal vein. Mclndoe (1928), studying the
vascular lesions of portal cirrhosis, noted that metastatic tumours were supplied
by the hepatic artery. Since then many published reports have confirmed this
finding both in human material and experimental tumours (see Table III).
TABLE III.-Published Work Supporting Hepatic Arterial Supply to Liver Tumours
Neoplasms in which hepatic
arterial rather than portal
venous supply has been
demonstrated
Human primary hepatic
neoplasms
Human metastatic hepatic
neoplasms
Experimental primary hepatic
neoplasms
Experimental metastatic
hepatic neoplasms.
Source
Bierman et al. (1957)
Mann et al. (1952)
Segall (1923)
McIndoe (1928)
Wright (1938)
Breedis and Young (1954)
Bierman et al. (1957)
Healey (1965)
Krishna Murthy (1959)
Gullino and Grantham (1962)
Nilsson et al. (1967)
Kanno (1934)
Kraus and Beltran (1959)
Fisher et al. (1961)
Hirono (1964)
Balashev (1965)
Blanchard et al. (1965)
Methods
Angiography
Vynyl casts
Gelatin casts
Vynyl casts
Gelatin casts
Gelatin casts
Angiography
Vynyl casts
Indian ink injection
Vynyl casts
Microangiography
Angiography
Ligation and tumour survival
experiments
Indian ink injections
Ligation and tumour survival
experiments
Histology
Radioactive microspheres
Honjo and Matsumara (1965), however, using carmine gelatin injection and
histology, described variable findings in rat hepatic tumours. In primary hepatic
tumours induced with 3-methyl DAB, they found that cholangiocarcinoma
appeared to be nourished exclusively by arterial blood, but that hepatoma showed
both arterial and portal blood supply. The supply to implanted Walker 256
carcinoma was primarily arterial but in marginal areas portal supply could also be
demonstrated. Nilsson et al. (1967) found some evidence of portal supply to rat
hepatoma induced in the same way.
It might be expected that the experiments in which ligation of the hepatic
artery was practised would demonstrate tumour necrosis and regression when
the principal blood supply was thus removed but the reports are conflicting.
Nilsson et al. (1967) found that after hepatic artery ligation the arterially supplied
cholangiocellular tumours and secondary tumours in rat liver showed marked
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necrosis, but hepatocellular tumours with a dual supply tended to survive.
Hirono (1964) found no change in the survival time, growth rate, or incidence
of metastasis in a variety of tumours implanted into rat liver, when the hepatic
artery was ligated 7 days later. Indeed, he claimed improved survival after
ligation of the portal vein, as did Kraus and Beltran (1959) using Walker 256
carcinoma. Fisher et al. (1961) confirmed the arterial supplytohepaticmetastases,
but gave evidence of an augmented " take rate " in animals whose hepatic arteries
or portal veins were ligated just before or within 72 hours after inoculation with
tumour cells. These findings are difficult to explain in terms ofinformation on the
source of tumour vasculature, and it is planned to study this in a further series of
experiments, examining the morphology of tumour circulation after ligation of
the hepatic artery. However, it seems clear that when the choice exists, a growing
metastatic tumour in the liver draws its circulation preferentially from the hepatic
artery. This may be understood on the basis of the presence of a capillary
venous hypertension in the tumour circulation (however it may be mediated)
requiring an afferent supply of greater than portal venous pressure. The possi-
bility of the higher oxygen tension in the hepatic arterial blood being the factor
influencing the selection must be considered. Miller (1967) believes that the low
oxygen tension in the liver plays a part in determining the high frequency and
large size of hepatic metastases, but other factors must surely be involved.
Willis (1952), commenting on the frequency of metastatic tumour in the liver,
suggests that the high " nutritive " quality of the portal blood may be important
in providing a favourable environment. This view if certainly not supported by
existing experimental work. It may well be that the morphology of the hepatic
vasculature with wide sinusoids and incomplete vessel walls, in association with a
slow rate of flow are the important features. Tumour emboli may be easily
arrested and less subject to early thrombus formation which renders non-viable
so many potential metastases in other sites. An experiment in which the oxygen
tensions in the arterial and venous supplies to the liver were reversed might further
clarify the problem. Notwithstanding these hypothetical considerations, the
present evidence seems to indicate that the pressure of the afferent blood supply
is of importance. It may be of critical importance in the establishment of metas-
tatic tumour generally, and further experiments in this field are planned.
SUMMARY
1. Evidence is presented indicating that in Brown-Pearce carcinoma implanted
in the liver, the tumour is nourished almost exclusively by the hepatic artery.
2. The possible significance ofthis findinginrelationtotheexistence ofcapillary-
venous hypertension in the tumour circulation is discussed.
3. The literature is briefly reviewed.
4. A programme of further experimental work is suggested.
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